G E Sale
Overview
Explore the profile of G E Sale including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
2115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Complement component C3 mediates Th1/Th17 polarization in human T-cell activation and cutaneous GVHD
Ma Q, Li D, Carreno R, Patenia R, Tsai K, Xydes-Smith M, et al.
Bone Marrow Transplant
. 2014 Apr;
49(7):972-6.
PMID: 24777193
The complement system has been shown to regulate T-cell activation and alloimmune responses in GVHD. Mice deficient in the central component of complement system C3 have significantly lower GVHD-related mortality/morbidity,...
2.
El-Gazzar A, Cai X, Reeves R, Dai Z, Caballero-Benitez A, McDonald D, et al.
Oncogene
. 2013 Oct;
33(41):4932-40.
PMID: 24141776
The stimulatory NKG2D lymphocyte receptor together with its tumor-associated ligands enable the immune system to recognize and destroy cancer cells. However, with dynamic changes unfolding, cancers exploit NKG2D and its...
3.
Yunusov M, Kuhr C, Georges G, Sale G, Spector M, Lesnikova M, et al.
Transplant Proc
. 2002 Dec;
34(8):3366-7.
PMID: 12493475
No abstract available.
4.
Torok-Storb B, Bolles L, Iwata M, Doney K, Sale G, Gooley T, et al.
Blood
. 2001 Aug;
98(3):891-2.
PMID: 11482318
No abstract available.
5.
Hagglund H, McSweeney P, Mathioudakis G, Bruno B, Georges G, Gass M, et al.
Transplantation
. 2000 Dec;
70(10):1437-42.
PMID: 11118086
Background: The aims of this study were to ex vivo expand canine dendritic cells and determine their phenotype and functional characteristics. Methods: CD34+-selected cells and CD34+-depleted canine bone marrow (BM)...
6.
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study
Curtis R, Travis L, Rowlings P, Socie G, Kingma D, Banks P, et al.
Blood
. 1999 Sep;
94(7):2208-16.
PMID: 10498590
We evaluated 18,014 patients who underwent allogeneic bone marrow transplantation (BMT) at 235 centers worldwide to examine the incidence of and risk factors for posttransplant lymphoproliferative disorders (PTLD). PTLD developed...
7.
van Burik J, Leisenring W, Myerson D, Hackman R, Shulman H, Sale G, et al.
Medicine (Baltimore)
. 1998 Aug;
77(4):246-54.
PMID: 9715729
We reviewed 355 autopsies performed between 1990 and 1994 at a major marrow transplant center to determine whether fluconazole prophylaxis prevented visceral fungal infection. Fluconazole prophylaxis was defined by a...
8.
Strasser S, Kowdley K, Sale G, McDonald G
Bone Marrow Transplant
. 1998 Aug;
22(2):167-73.
PMID: 9707025
We examined the degree of hepatic iron overload in patients receiving marrow transplant for hematologic malignancy and evaluated a new method of morphometric analysis of marrow iron content as a...
9.
Wells D, Sale G, Shulman H, Myerson D, Bryant E, Gooley T, et al.
Am J Clin Pathol
. 1998 Jul;
110(1):84-94.
PMID: 9661926
Serial bone marrow aspirates from patients previously given a diagnosis of acute lymphoblastic leukemia (ALL) who had undergone chemotherapy, bone marrow transplantation (BMT), or both were analyzed by multidimensional flow...
10.
Ko C, Gooley T, Schoch H, Myerson D, Hackman R, Shulman H, et al.
Bone Marrow Transplant
. 1998 Feb;
20(12):1081-6.
PMID: 9466282
Pancreatitis has been described as an infrequent complication of marrow transplantation. This study investigated the prevalence of pancreatitis at autopsy in marrow transplant patients and determined risk factors for its...